-
Mashup Score: 6Longitudinal gut microbiome analyses and blooms of pathogenic strains during lupus disease flares - 9 month(s) ago
Objective Whereas genetic susceptibility for systemic lupus erythematosus (SLE) has been well explored, the triggers for clinical disease flares remain elusive. To investigate relationships between microbiota community resilience and disease activity, we performed the first longitudinal analyses of lupus gut-microbiota communities. Methods In an observational study, taxononomic analyses,…
Source: Annals of the Rheumatic DiseasesCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 1Biomarker reduction indicates treatment response to Belimumab - 10 month(s) ago
Dr. Anna Wolska from the Lupus Foundation of America interviews Dr. Andrea Fava from Johns Hopkins University about Belimumab treatment in lupus nephritis. Dr Fava elucidates on the correlation betwee
Source: SoundCloudCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 1Biomarker reduction indicates treatment response to Belimumab - 10 month(s) ago
Dr. Anna Wolska from the Lupus Foundation of America interviews Dr. Andrea Fava from Johns Hopkins University about Belimumab treatment in lupus nephritis. Dr Fava elucidates on the correlation betwee
Source: SoundCloudCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 0Effect of Nonimmune Factors on Renal Prognosis in Adult IgA Vasculitis With Nephritis: A Long-Term Retrospective Cohort Study - 10 month(s) ago
Objective Adult immunoglobulin A vasculitis (IgAV) is documented to be associated with more renal involvement and poorer renal outcomes compared to children, but adult IgAV nephritis (IgAV-N) data are rather limited. The present study aimed to describe the characteristics of adult IgAV-N and investigate the long-term prognostic factors. Methods Clinical and morphological data from 106 adult…
Source: The Journal of RheumatologyCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 1Biomarker reduction indicates treatment response to Belimumab - 10 month(s) ago
Dr. Anna Wolska from the Lupus Foundation of America interviews Dr. Andrea Fava from Johns Hopkins University about Belimumab treatment in lupus nephritis. Dr Fava elucidates on the correlation betwee
Source: SoundCloudCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 0Lupus Science & Medicine: 10 (1) - 1 year(s) ago
Brief communication Genetic load in incomplete lupus erythematosus (4 January, 2023) , Joseph M Kheir, Miles Smith, Colin Mowery, Susan Macwana, Wade DeJager, Catriona A Wagner, Teresa Aberle, Judith A James, Joel M Guthridge Epidemiology and outcomes Original research: A better self-efficacy is predictive of better health-related quality of life…
Source: Lupus Science & MedicineCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 5JCI Insight - Tertiary lymphoid structure signatures are associated with immune checkpoint inhibitor related acute interstitial nephritis - 1 year(s) ago
ResearchIn-Press PreviewImmunologyNephrology Open Access | 10.1172/jci.insight.165108 James P. Long,2 Amanda Tchakarov,3 Yanlan Dong,4 Cassian Yee,1 and Jamie S. Lin4 1Department of Melanoma Medical Oncology, UT MD Anderson Cancer Center, Houston, United States of America2Department of Biostatistics, UT MD Anderson Cancer Center, Houston,…
Source: insight.jci.orgCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 1Latest articles for Lupus Science & Medicine - 1 year(s) ago
BMJ is a healthcare knowledge provider with a vision for a healthier world. We share knowledge and expertise to improve healthcare outcomes. Visit: https://www.bmj.com/company/. If you would like to find out more about how BMJ manages your data, please read our privacy notice and cookie policy. To view BMJ’s privacy notice visit:…
Source: emails.bmj.comCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 0Latest articles for Lupus Science & Medicine - 1 year(s) ago
BMJ is a healthcare knowledge provider with a vision for a healthier world. We share knowledge and expertise to improve healthcare outcomes. Visit: https://www.bmj.com/company/. If you would like to find out more about how BMJ manages your data, please read our privacy notice and cookie policy. To view BMJ’s privacy notice visit:…
Source: emails.bmj.comCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 0Latest articles for Lupus Science & Medicine - 1 year(s) ago
BMJ is a healthcare knowledge provider with a vision for a healthier world. We share knowledge and expertise to improve healthcare outcomes. Visit: https://www.bmj.com/company/. If you would like to find out more about how BMJ manages your data, please read our privacy notice and cookie policy. To view BMJ’s privacy notice visit:…
Source: emails.bmj.comCategories: Latest Headlines, RheumatologyTweet
⚠️ New kid on the block among triggers of #flares in #lupus #nephritis 🦋 📈 Longitudinal gut #microbiota analysis 🔬 💥 #Ruminococcus gnavus bloomed during flares 🆕 Novel immunogenic #lipoglycan recognised by IgG2 🆙 specific #IgG2 ⬆️ ⬆️ in flares https://t.co/MpdETeo7iY https://t.co/dLmS0L4k8j